PT  - JOURNAL ARTICLE
AU  - Alexander, Lori
ED  - Zeymer, Uwe
TI  - Comparison of Eptifibatide and Abciximab as Adjunct to Primary PCI
DP  - 2007  01
TA  - MD Conference Express
PG  - 21--21
VI  - 7
IP  - 7
4099  - http://mdc.sagepub.com/content/7/7/21.1.short
4100  - http://mdc.sagepub.com/content/7/7/21.1.full
AB  - The EVA-AMI trial compared two intravenous glycoprotein IIb/IIIa inhibitors (GPI), eptifibatide and abciximab, as adjuncts to primary percutaneous coronary intervention (PCI) with respect to several measures of myocardial perfusion. The study represents the first head-to-head comparison of two GPIs in primary PCI for ST-elevation myocardial infarction.